dengue

Dengue vaccine, early trial


Overview

Results from an early trial for a vaccine for Dengue fever. Patients were randomized into two groups. Patients in the treatment group received the vaccine, and those in the control group received a placebo. After 6 months, each patient was injected with a weaker virus of Dengue. Researchers subsequently took blood measurements, inspecting if any virus was present, and also reported if any rash developed.


Variables

  • condition: What the patient received, either the vaccine or a placebo.
  • virus.in.blood: Whether a patient had Dengue virus present in her / his blood.
  • develop.rash: Whether a patient developed a rash.


Loading Data

CSV Download

To access the data in R, type

source("http://www.openintro.org/books/statdata/dengue.R")

To access the data in SAS, type

filename dengue url 'http://www.openintro.org/books/statdata/dengue.csv'